NASDAQ:SNDX

Syndax Pharmaceuticals News Headlines

$15.42
+0.36 (+2.39 %)
(As of 05/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$15.20
$16.10
50-Day Range
$13.42
$25.18
52-Week Range
$13.02
$27.85
Volume394,511 shs
Average Volume848,156 shs
Market Capitalization$743.80 million
P/E RatioN/A
Dividend YieldN/A
Beta1.8

Headlines

Syndax Pharmaceuticals (NASDAQ SNDX) News Headlines Today

SourceHeadline
Syndax Pharmaceuticals (SNDX) to Release Earnings on TuesdaySyndax Pharmaceuticals (SNDX) to Release Earnings on Tuesday
americanbankingnews.com - May 5 at 10:56 AM
Syndax to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11, 2021Syndax to Announce First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11, 2021
finance.yahoo.com - May 4 at 7:35 AM
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Recommendation of "Buy" from BrokeragesSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Receives Average Recommendation of "Buy" from Brokerages
americanbankingnews.com - May 3 at 2:58 AM
Dennis Podlesak Is The Independent Chairman of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) And Just Spent US$197k On SharesDennis Podlesak Is The Independent Chairman of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) And Just Spent US$197k On Shares
finance.yahoo.com - April 25 at 8:57 AM
Syndax Pharmaceuticals Stock Appears To Be Significantly OvervaluedSyndax Pharmaceuticals Stock Appears To Be Significantly Overvalued
uk.finance.yahoo.com - April 24 at 8:04 AM
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 7.1% After Insider Buying ActivitySyndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 7.1% After Insider Buying Activity
americanbankingnews.com - April 23 at 10:28 AM
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Director Dennis Podlesak Acquires 13,967 SharesSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Director Dennis Podlesak Acquires 13,967 Shares
americanbankingnews.com - April 22 at 7:36 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Down  Following Analyst DowngradeSyndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Down Following Analyst Downgrade
americanbankingnews.com - April 22 at 10:24 AM
Syndax (SNDX) Moves 10.7% Higher: Will This Strength Last?Syndax (SNDX) Moves 10.7% Higher: Will This Strength Last?
finance.yahoo.com - April 22 at 10:18 AM
Syndax Pharmaceuticals (NASDAQ:SNDX) Sees Large Volume IncreaseSyndax Pharmaceuticals (NASDAQ:SNDX) Sees Large Volume Increase
americanbankingnews.com - April 21 at 12:58 PM
46 Biggest Movers From Yesterday46 Biggest Movers From Yesterday
msn.com - April 21 at 8:33 AM
Syndax Pharmaceuticals (NASDAQ:SNDX) PT Lowered to $30.00 at Robert W. BairdSyndax Pharmaceuticals (NASDAQ:SNDX) PT Lowered to $30.00 at Robert W. Baird
americanbankingnews.com - April 21 at 8:28 AM
Syndax Pharmaceuticals (NASDAQ:SNDX) Earns "Buy" Rating from B. RileySyndax Pharmaceuticals (NASDAQ:SNDX) Earns "Buy" Rating from B. Riley
americanbankingnews.com - April 21 at 8:28 AM
Syndax Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:SNDX)Syndax Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:SNDX)
americanbankingnews.com - April 21 at 4:26 AM
Why Syndax Pharmaceuticals Stock Is Sinking TodayWhy Syndax Pharmaceuticals Stock Is Sinking Today
finance.yahoo.com - April 20 at 7:38 PM
31 Stocks Moving In Tuesdays Mid-Day Session31 Stocks Moving In Tuesday's Mid-Day Session
msn.com - April 20 at 2:38 PM
Syndax Lower as Blood Cancer Drug Trial Disappoints InvestorsSyndax Lower as Blood Cancer Drug Trial Disappoints Investors
finance.yahoo.com - April 20 at 2:38 PM
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Up to $19.38Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Up to $19.38
americanbankingnews.com - April 20 at 11:36 AM
Why Crispr, KalVista And Syndax Are Moving TodayWhy Crispr, KalVista And Syndax Are Moving Today
markets.businessinsider.com - April 20 at 9:37 AM
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Sees Significant Growth in Short InterestSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Sees Significant Growth in Short Interest
americanbankingnews.com - April 19 at 10:52 AM
Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Down to $20.98Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Down to $20.98
americanbankingnews.com - April 17 at 8:42 AM
Syndax Pharmaceuticals to Host Conference Call and Webcast to Provide Updated Data from Phase 1 Portion of AUGMENT-101 Trial of SNDX-5613 in Patients with Acute LeukemiasSyndax Pharmaceuticals to Host Conference Call and Webcast to Provide Updated Data from Phase 1 Portion of AUGMENT-101 Trial of SNDX-5613 in Patients with Acute Leukemias
finance.yahoo.com - April 15 at 7:51 AM
Syndax Pharma’s Axatilimab Receives Orphan Drug Designation For Treatment Of Chronic Lung DiseaseSyndax Pharma’s Axatilimab Receives Orphan Drug Designation For Treatment Of Chronic Lung Disease
finance.yahoo.com - April 9 at 12:19 PM
Syndax Announces Orphan Drug Designation Granted to Axatilimab for Treatment of Idiopathic Pulmonary FibrosisSyndax Announces Orphan Drug Designation Granted to Axatilimab for Treatment of Idiopathic Pulmonary Fibrosis
finance.yahoo.com - April 8 at 9:13 PM
Is SNDX Stock A Buy or Sell?Is SNDX Stock A Buy or Sell?
finance.yahoo.com - April 8 at 4:13 PM
Syndax Announces Orphan Drug Designation Granted to Axatilimab for Treatment of Chronic Graft Versus Host DiseaseSyndax Announces Orphan Drug Designation Granted to Axatilimab for Treatment of Chronic Graft Versus Host Disease
finance.yahoo.com - March 31 at 7:23 AM
Is Syndax Pharmaceuticals (NASDAQ:SNDX) Using Debt In A Risky Way?Is Syndax Pharmaceuticals (NASDAQ:SNDX) Using Debt In A Risky Way?
finance.yahoo.com - March 15 at 5:07 PM
Syndax Pharmaceuticals, Inc. (SNDX) CEO Dr. Briggs Morrison on Q4 2020 Results - Earnings Call TranscriptSyndax Pharmaceuticals, Inc. (SNDX) CEO Dr. Briggs Morrison on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 10 at 6:15 PM
Syndax Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call PresentationSyndax Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 9 at 5:29 PM
Syndax Posts Better-Than-Feared Quarterly Loss, Sales Beat EstimatesSyndax Posts Better-Than-Feared Quarterly Loss, Sales Beat Estimates
finance.yahoo.com - March 9 at 7:03 AM
Syndax: Q4 Earnings SnapshotSyndax: Q4 Earnings Snapshot
finance.yahoo.com - March 8 at 8:52 PM
Syndax Pharmaceuticals Reports Fourth Quarter 2020 Financial Results and Provides Clinical and Business UpdateSyndax Pharmaceuticals Reports Fourth Quarter 2020 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - March 8 at 8:52 PM
Syndax Pharmaceuticals: Q4 Earnings InsightsSyndax Pharmaceuticals: Q4 Earnings Insights
finance.yahoo.com - March 8 at 8:52 PM
Syndax to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 8, 2021Syndax to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 8, 2021
finance.yahoo.com - March 1 at 8:01 AM
Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology IndexSyndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index
finance.yahoo.com - December 18 at 7:34 AM
Syndax Announces Closing of Public Offering and Exercise in Full of the Underwriters Option to Purchase Additional SharesSyndax Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
finance.yahoo.com - December 11 at 8:39 PM
Implied Volatility Surging for Syndax Pharmaceuticals (SNDX) Stock OptionsImplied Volatility Surging for Syndax Pharmaceuticals (SNDX) Stock Options
nasdaq.com - December 7 at 5:09 PM
News for Syndax Pharmaceuticals IncNews for Syndax Pharmaceuticals Inc
markets.businessinsider.com - November 30 at 5:08 PM
Syndax Pharmaceuticals to Host Axatilimab Conference Call and Webcast Featuring Two cGVHD ExpertsSyndax Pharmaceuticals to Host Axatilimab Conference Call and Webcast Featuring Two cGVHD Experts
finance.yahoo.com - November 30 at 8:31 AM
Syndax Announces Presentation at Stifel 2020 Virtual Healthcare ConferenceSyndax Announces Presentation at Stifel 2020 Virtual Healthcare Conference
finance.yahoo.com - November 11 at 7:53 AM
Syndax Pharmaceuticals to Present Updated Data from Phase 1 Trial of Axatilimab in cGVHD During Oral Session at the 62nd ASH Annual MeetingSyndax Pharmaceuticals to Present Updated Data from Phase 1 Trial of Axatilimab in cGVHD During Oral Session at the 62nd ASH Annual Meeting
finance.yahoo.com - November 4 at 5:40 PM
Heres what Wall Street expects from Syndax Pharmaceuticalss earnings reportHere's what Wall Street expects from Syndax Pharmaceuticals's earnings report
markets.businessinsider.com - November 3 at 3:09 PM
Syndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2020 Results - Earnings Call TranscriptSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 3 at 9:54 AM
Syndax Pharmaceuticals EPS misses by $0.02, misses on revenueSyndax Pharmaceuticals EPS misses by $0.02, misses on revenue
seekingalpha.com - November 2 at 6:26 PM
Syndax Pharmaceuticals, Inc. to Host Earnings CallSyndax Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 2 at 6:26 PM
Syndax Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Business UpdateSyndax Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Business Update
finance.yahoo.com - November 2 at 6:26 PM
Syndax to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 2, 2020Syndax to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 2, 2020
finance.yahoo.com - October 26 at 7:08 AM
The Syndax Pharmaceuticals (NASDAQ:SNDX) Share Price Is Up 152% And Shareholders Are Boasting About ItThe Syndax Pharmaceuticals (NASDAQ:SNDX) Share Price Is Up 152% And Shareholders Are Boasting About It
finance.yahoo.com - October 21 at 2:20 PM
Syndax Pharmaceuticals Inc. Reg (1T3.SG)Syndax Pharmaceuticals Inc. Reg (1T3.SG)
ca.finance.yahoo.com - October 17 at 11:00 PM
Is Syndax Pharmaceuticals (NASDAQ:SNDX) A Risky Investment?Is Syndax Pharmaceuticals (NASDAQ:SNDX) A Risky Investment?
finance.yahoo.com - September 3 at 5:22 PM
This page was last updated on 5/6/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.